Ignite Creation Date:
2024-05-05 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00310739
Status:
UNKNOWN
Last Update Posted:
2006-11-07
First Post:
2006-04-03
Brief Title:
Urinary Marker for Oxidative Stress in Human Cisplatin- Induced Renal Injury
Sponsor:
Hamamatsu University
Organization:
Hamamatsu University
Study Overview
Official Title:
None
Status:
UNKNOWN
Status Verified Date:
2005-04
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We previously reported early measurement of urinary MDA might be a useful marker for the prediction of CDDP-induced renal damage in rat The purpose of this clinical study is to test whether the changes of human urinary excretion of MDA and can be used as early biomarker for the prediction of development of CDDP-induced ARF
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None